Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869024 · ClinicalTrials.gov registry record · Phase 1
Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00869024 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 25 participants.
The verdict
NCT00869024, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the delivery of cells just after implantation of left ventricular assist device will help to improve the pumping function of your heart and minimize heart enlargement in the future. The cells will be obtained by aspiration or withdrawal of fluid from your bone marrow from your pelvic bone using a needle and syringe. This would not take place until 24-48 hours prior to your planned left ventricular assist device implantation. During the surgery the surgeons will inject the prepared cells that were taken from your bone marrow and inject it into your heart muscle. This study will test whether receiving your own bone marrow cells directly into your heart will help your heart to recover function after placement of a left ventricular assist device.
Interventions
- BIOLOGICAL Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-11-10 |
| Est. Completion | 2016-03-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869024
The ClinicalTrials.gov registry entry for NCT00869024 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells is the first listed.
NCT00869024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869024 about?
NCT00869024 is a clinical study titled "Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement". The purpose of this study is to determine if the delivery of cells just after implantation of left ventricular assist device will help to improve the pumping function of your heart and minimize heart enlargement in the future. The cells will be obtained by aspiration or withdrawal of fluid from you...
What is the current status of trial NCT00869024?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2011-11-10. Estimated completion is 2016-03-29.
What interventions are being tested in trial NCT00869024?
The interventions under investigation include: Intramyocardial Delivery of Bone Marrow Derived Mononuclear Cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00869024?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.